Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A licensed provider still reviews your health history to determine if semaglutide is appropriate for you
Medical literature suggests that if measurable amounts do transfer to breast milk, the peptide's molecular size and gastrointestinal degradation would prevent meaningful absorption in an infant's GI tract
Delanian S, Martin M, Bravard A, Luccioni C, Lefaix JL
What you're paying for with brand-name Wegovy: FDA-approved manufacturing process with batch testing Pre-filled single-dose pens (no reconstitution required) Dosing consistency guaranteed by FDA oversight Novo Nordisk's clinical trial safety database Eligibility for manufacturer patient assistance programs What you're getting with compounded semaglutide: The same active ingredient (semaglutide) at the same doses Prepared by a state-licensed 503B compounding pharmacy Multi-dose vials requiring reconstitution and self-measurement No FDA approval or batch testing (compounded medications are exempt from FDA approval requirements under the Federal Food, Drug, and Cosmetic Act Section 503B) Lower cost due to lack of brand-name markup Compounded semaglutide is not FDA-approved and is not interchangeable with Wegovy
Furthermore, when compared to patients not taking any of these other medications, the GLP-1 group displayed a recurrence risk of 14.5%, whereas the comparison group had a risk of 51.6%
US$ 24.29
US$ 21.79
US$ 20.86
.png)
US$ 26.93
